Riverinemounts Biosys Private Limited
Founded in 1998 and headquartered in Maharashtra, India.
1998 | Pune, Maharashtra (India) | Active
Riverinemounts Biosys Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.67 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -6964.30%
- Ebitda -31483.44%
- Net Worth -24.50%
- Total Assets -23.78%
About Riverinemounts Biosys
Riverinemounts Biosys Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 July 1998 and has a history of 26 years and seven months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.67 M, as per Ministry of Corporate Affairs (MCA) records.
Vinayak Bhosale and Sanjay Bhosale serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239PN1998PTC012730
- Company No.
012730
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 1998
- Date of AGM
01 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Chemicals
Pharmaceuticals
Who are the key members and board of directors at Riverinemounts Biosys?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinayak Bhosale  | Director | 27-Jul-1998 | Current |
| Sanjay Bhosale | Director | 22-May-2019 | Current |
Financial Performance of Riverinemounts Biosys.
Riverinemounts Biosys Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 6964.3% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riverinemounts Biosys?
Unlock access to Riverinemounts Biosys's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Upanishadam Welfare And Research Foundation
Vinayak Bhosale is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Riverinemounts Biosys?
Unlock and access historical data on people associated with Riverinemounts Biosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riverinemounts Biosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riverinemounts Biosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
